Glucose exposure pattern determines glucagon-like peptide 1 receptor expression and signaling through endoplasmic reticulum stress in rat insulinoma cells

2011 ◽  
Vol 414 (1) ◽  
pp. 220-225 ◽  
Author(s):  
Ye-Hwang Cheong ◽  
Mi-Kyung Kim ◽  
Moon-Ho Son ◽  
Bong-Kiun Kaang
Diabetes ◽  
2009 ◽  
Vol 58 (12) ◽  
pp. 2851-2862 ◽  
Author(s):  
Daniel A. Cunha ◽  
Laurence Ladrière ◽  
Fernanda Ortis ◽  
Mariana Igoillo-Esteve ◽  
Esteban N. Gurzov ◽  
...  

1990 ◽  
Vol 126 (3) ◽  
pp. 445-450 ◽  
Author(s):  
G. Richter ◽  
R. Göke ◽  
B. Göke ◽  
R. Arnold

ABSTRACT The effect of dexamethasone on binding of glucagonlike peptide-1(7–36)amide (GLP-1(7–36)amide) to rat insulinoma-derived cells (RINm5F) was investigated. Preincubation of RINm5F cells with dexamethasone (100 nmol/l) for 24 h resulted in a decrease of GLP1(7-36)amide binding to 55·0±8·16% (mean ± s.e.m.), incubation for 48 h to 39·1±1·76%, and for 72 h to 15·5±4·35% of maximal binding. The GLP-1(7–36)amide-induced stimulation of cyclic AMP (cAMP) production was significantly decreased to 61·03±7·4% of maximum production in cells pretreated with dexamethasone (100 nmol/l) for 48 h. The decreased binding was due to a reduction of the receptor number while the receptor affinity remained unchanged. These inhibitory effects on binding and cAMP formation induced by dexamethasone were completely abolished when the antiglucocorticoid RU 38486 (100 nmol/l) was added during preincubation with dexamethasone. RU 38486 alone had no effects. Our data suggest that the biological action of GLP-1(7–36) amide at the B-cell may be modified by glucocorticoids. Journal of Endocrinology (1990) 126, 445–450


1989 ◽  
Vol 189 (4) ◽  
pp. 257-264 ◽  
Author(s):  
R. Göke ◽  
G. Richter ◽  
B. Göke ◽  
M. Trautmann ◽  
R. Arnold

Metabolism ◽  
2014 ◽  
Vol 63 (6) ◽  
pp. 800-811 ◽  
Author(s):  
Hiroto Hayashi ◽  
Ren Yamada ◽  
Siddhartha Shankar Das ◽  
Taiki Sato ◽  
Aki Takahashi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document